Jacob S. Schneiderman

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Intrarenal Anti-Leptin Treatment Attenuates Ischemia and Reperfusion Injury.

Intrarenal Anti-Leptin Treatment Attenuates Ischemia and Reperfusion Injury.

Journal: American journal of nephrology

Published: February 01, 2023

Intraarterial anti-leptin therapy via ICA protects ipsilateral CA1 neurons subjected to ischemia and reperfusion.

Intraarterial anti-leptin therapy via ICA protects ipsilateral CA1 neurons subjected to ischemia and reperfusion.

Journal: PloS one

Published: November 02, 2020

Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.

Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.

Journal: Journal of the American Heart Association

Published: May 08, 2020

Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction.

Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction.

Journal: PloS one

Published: June 28, 2018

Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 07, 2016

Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.

Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.

Journal: Journal of the American Heart Association

Published: May 05, 2016

Phase I study of multi-gene cell therapy in patients with peripheral artery disease.

Phase I study of multi-gene cell therapy in patients with peripheral artery disease.

Journal: Vascular medicine (London, England)

Published: November 21, 2015

Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Journal: Gene therapy

Published: March 29, 2015

Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms.

Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms.

Journal: Journal of the American Society of Hypertension : JASH

Published: April 01, 2014

Endovascular repair of complex aortic aneurysms.

Endovascular repair of complex aortic aneurysms.

Journal: The Israel Medical Association journal : IMAJ

Published: March 01, 2014

Endovascular treatment of lower extremity ischemia in chronic renal failure patients on dialysis: early and intermediate term results.

Endovascular treatment of lower extremity ischemia in chronic renal failure patients on dialysis: early and intermediate term results.

Journal: The Israel Medical Association journal : IMAJ

Published: January 24, 2014

The deep femoral artery, a readily available inflow vessel for lower limb revascularization: a single-center experience.

The deep femoral artery, a readily available inflow vessel for lower limb revascularization: a single-center experience.

Journal: Vascular

Published: March 20, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026